Prosecution Insights
Last updated: August 15, 2026

BPGbio, Inc.

2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days

Portfolio Summary

2
Total Pending OAs
2
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (50%)
0
Medium (0%)
1
Easy (50%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (50%)
Double-patenting only1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
50% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SANG, HONG 1 54.7% +62.6%
CLOW, LORI A 1 64.0% +28.6%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18125524 INTERROGATORY CELL-BASED ASSAYS AND USES THEREOF CLOW, LORI A

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18523239 FILAMIN A BINDING PROTEINS AND USES THEREOF SANG, HONG
18125524 INTERROGATORY CELL-BASED ASSAYS AND USES THEREOF CLOW, LORI A

Top Art Units

Art UnitApps
1671 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18523239 FILAMIN A BINDING PROTEINS AND USES THEREOF SANG, HONG DP Non-Final OA Pending Nov 29, 2023
18125524 INTERROGATORY CELL-BASED ASSAYS AND USES THEREOF CLOW, LORI A 1671 §101 Non-Final OA Pending Mar 23, 2023

Managing BPGbio, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month